A newly revealed molecular tug-of-war may have implications for better understanding how a multitude of diseases and ...

BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...

While the 21st century has been bumpy, it has also ushered in monumental scientific and technological breakthroughs that have ...

African Swine Fever Virus, ASFV, Viral Entry, Host Cell Invasion, CD163, Siglec-1, Macropinocytosis, Endosomal Escape, Immune Evasion, Signaling Pathways Share and Cite: Marcelino, K.B. and Fang, G.J.

The abstract will be published in the peer-reviewed Metabolism: Experimental and Clinical. The presentation will be available on Biomea Fusion's Investor Relations Page under the Events. Please find a ...

Biomea Fusion (BMEA) announced that it presented COVALENT-111 study results at the 23rd World Congress on Insulin Resistance, Diabetes & ...

SAN CARLOS, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that ...

The race is on to harness the near-infinite power of nuclear fusion—by building a star on Earth. And scientists are closer than you might think. Nuclear fusion in the sun occurs when hydrogen is ...

Scientists demonstrated that glial fibrillary acidic protein (GFAP) promotes mitochondrial fission rather than blocking fusion. The genetic disorder Alexander disease is caused by mutations in the ...

South African mobile-network operator Cell C Holdings Ltd. opened flat in its debut on the Johannesburg Stock Exchange, with the continent’s top bourse on track for its best year for funds raised from ...

Cell C listed on the JSE on Thursday, completing a multi-year turnaround that not only reshaped the business but rescued it from the jaws of business collapse. The shares began trading on Thursday ...

South African mobile operator Cell C has raised about R2.7bn ($156m) through a share offer ahead of listing on the Johannesburg Stock Exchange (JSE) this week. The offer, which closed on 21 November, ...